These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


113 related items for PubMed ID: 3226444

  • 1. Effect of short-term inhibition of prostaglandin synthesis on glomerular filtration rate and microalbuminuria in patients with incipient diabetic nephropathy.
    van den Berg BW, Kruseman AC, van Geel JL, Cornelissen P, Mulder AW.
    Neth J Med; 1988 Oct; 33(3-4):106-12. PubMed ID: 3226444
    [No Abstract] [Full Text] [Related]

  • 2. Elevated urinary prostaglandin excretion and the effect of indomethacin on renal function in incipient diabetic nephropathy.
    Mathiesen ER, Hommel E, Olsen UB, Parving HH.
    Diabet Med; 1988 Mar; 5(2):145-9. PubMed ID: 2964980
    [Abstract] [Full Text] [Related]

  • 3. Short term effect of an aldose reductase inhibitor on urinary albumin excretion rate (UAER) and glomerular filtration rate (GFR) in type 1 diabetic patients with incipient nephropathy.
    Ranganathan S, Krempf M, Feraille E, Charbonnel B.
    Diabete Metab; 1993 Mar; 19(2):257-61. PubMed ID: 8339858
    [Abstract] [Full Text] [Related]

  • 4. [The recovery of the kidney filtration functional reserve in diabetes mellitus patients on captopril treatment].
    Shestakova MV, Mukhin NA, Dedov II, Titov VN, Pomerantseva NV, Okunev DIu, Lipitskaia IIa.
    Ter Arkh; 1991 Mar; 63(6):50-5. PubMed ID: 1948747
    [Abstract] [Full Text] [Related]

  • 5. Glomerular filtration rate and albuminuria: twin manifestations of nephropathy in diabetes.
    de Boer IH, Steffes MW.
    J Am Soc Nephrol; 2007 Apr; 18(4):1036-7. PubMed ID: 17360946
    [No Abstract] [Full Text] [Related]

  • 6. [Diabetic nephropathy in children and adolescents].
    Dumas R.
    Arch Pediatr; 1994 May; 1(5):455-7. PubMed ID: 7951828
    [No Abstract] [Full Text] [Related]

  • 7. Aldosterone synthase (CYP11B2)-344T/C polymorphism and renoprotective response to losartan treatment in diabetic nephropathy.
    Schjoedt KJ, Lajer M, Andersen S, Tarnow L, Rossing P, Parving HH.
    Scand J Clin Lab Invest; 2006 May; 66(3):173-80. PubMed ID: 16714246
    [Abstract] [Full Text] [Related]

  • 8. Effect of sulphated glycosaminoglycans on albuminuria in patients with overt diabetic (type 1) nephropathy.
    Tamsma JT, van der Woude FJ, Lemkes HH.
    Nephrol Dial Transplant; 1996 Jan; 11(1):182-5. PubMed ID: 8649631
    [Abstract] [Full Text] [Related]

  • 9. Long-term renoprotection by perindopril or nifedipine in non-hypertensive patients with Type 2 diabetes and microalbuminuria.
    Jerums G, Allen TJ, Campbell DJ, Cooper ME, Gilbert RE, Hammond JJ, O'Brien RC, Raffaele J, Tsalamandris C, Melbourne Diabetic Nephropathy Study Group.
    Diabet Med; 2004 Nov; 21(11):1192-9. PubMed ID: 15498085
    [Abstract] [Full Text] [Related]

  • 10. Is glomerular filtration rate in children after 5 years of type 1 diabetes associated with development of albuminuria?
    Araki S.
    Nat Clin Pract Nephrol; 2006 May; 2(5):242-3. PubMed ID: 16932432
    [No Abstract] [Full Text] [Related]

  • 11. [Incipient diabetic nephropathy].
    Pennaforte S, Bosquet F, Grimaldi A.
    Ann Med Interne (Paris); 1987 May; 138(7):533-45. PubMed ID: 3326453
    [No Abstract] [Full Text] [Related]

  • 12. Effects of ACE inhibitors on renal function in incipient and overt diabetic nephropathy.
    Parving HH.
    J Diabetes Complications; 1996 May; 10(3):133-5. PubMed ID: 8807457
    [Abstract] [Full Text] [Related]

  • 13. The prevalence of glomerular hyperfiltration in type 1 (insulin-dependent) diabetes mellitus.
    Ciavarella A, Galuppi V, Forlani G, Vannini P.
    Diabete Metab; 1988 May; 14(1):73-4. PubMed ID: 3391330
    [No Abstract] [Full Text] [Related]

  • 14. Remission to normoalbuminuria during multifactorial treatment preserves kidney function in patients with type 2 diabetes and microalbuminuria.
    Gaede P, Tarnow L, Vedel P, Parving HH, Pedersen O.
    Nephrol Dial Transplant; 2004 Nov; 19(11):2784-8. PubMed ID: 15328385
    [Abstract] [Full Text] [Related]

  • 15. Contrasting renal functional reserve in very long-term Type I diabetic patients with and without nephropathy.
    Sackmann H, Tran-Van T, Tack I, Hanaire-Broutin H, Tauber JP, Ader JL.
    Diabetologia; 2000 Feb; 43(2):227-30. PubMed ID: 10753045
    [Abstract] [Full Text] [Related]

  • 16. [Diabetic nephropathy: glomerular filtration rate and estimated creatinine clearance].
    Guimarães J, Bastos M, Melo M, Carvalheiro M.
    Acta Med Port; 2007 Feb; 20(2):145-50. PubMed ID: 17868520
    [Abstract] [Full Text] [Related]

  • 17. Protein restriction, glomerular filtration rate and albuminuria in patients with type 2 diabetes mellitus: a randomized trial.
    Pijls LT, de Vries H, van Eijk JT, Donker AJ.
    Eur J Clin Nutr; 2002 Dec; 56(12):1200-7. PubMed ID: 12494305
    [Abstract] [Full Text] [Related]

  • 18. Effects of indomethacin on kidney function in type 1 (insulin-dependent) diabetic patients with nephropathy.
    Hommel E, Mathiesen E, Arnold-Larsen S, Edsberg B, Olsen UB, Parving HH.
    Diabetologia; 1987 Feb; 30(2):78-81. PubMed ID: 3471610
    [Abstract] [Full Text] [Related]

  • 19. Microalbuminuria in insulin-dependent diabetes--strategies to prevent diabetic nephropathy.
    Mathiesen ER.
    Nephron; 1993 Feb; 65(4):511-21. PubMed ID: 8302402
    [No Abstract] [Full Text] [Related]

  • 20. [Pathogenicity of glomerular hyperfiltration, a question of glomerular tolerance?].
    Wüstenberg PW, Dabels J.
    Z Gesamte Inn Med; 1990 Apr 15; 45(8):210-4. PubMed ID: 2198716
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 6.